Nama's AI scorecard currently rates Cardinal Health Buy (6.5 out of 10), a call computed from its profitability, cash generation, growth, valuation and balance sheet. It is a research reading, not investment advice.

What is CAH's P/E ratio?

Cardinal Health trades at a trailing price-to-earnings ratio of 23.3.

When does CAH report earnings?

Cardinal Health's next scheduled report is on Feb 4, 2027. Analysts expect EPS of $3.14.

What is the CAH price target?

The median analyst price target from 15 analysts is $277.00, with a range of $235.00 – $295.00.

Is CAH Shariah compliant?

Nama's AAOIFI-style screen reads Cardinal Health as Shariah Compliant. Passes our debt, cash and income screen; not a scholar's ruling.

Does CAH pay a dividend?

Yes — Cardinal Health's dividend yield is 0.8%.

Nama Insights

Cardinal Health (CAH)

Healthcare · Medical Distribution · NYSE

S&P 500

Cardinal Health (CAH) is a Healthcare company in the Medical Distribution industry. It has a market capitalization of $62.92B, a trailing price-to-earnings ratio of 23.3 and a free-cash-flow yield of 7.0%. Over the most recent reported fiscal year, revenue grew 14.2% and free cash flow per share grew 149.8%. Nama's AI scorecard rates it Buy, 6.5 out of 10. On 12-month momentum it ranks in the rising band of its market.

AI scorecard

Buy · 6.5/10

Positive, at the low end of Buy. As of Nov 7, 2026.

Momentum

Rising · +17.3% over 12 months ex. last

Second-best fifth of its market on the past year's move.

Shariah screen

Shariah Compliant

Passes our debt, cash and income screen; not a scholar's ruling.

Off its high

-5.1%

How far the last close sits under the highest price of the past five years.

Market cap	$62.92B
Trailing P/E	23.3
Price / book	—
Price / sales	0.2
FCF yield	7.0%
Dividend yield	0.8%
Gross margin	3.8%
Operating margin	1.2%
Net margin	0.7%
Revenue growth (YoY)	+14.2%
Revenue growth (3-yr annual)	+7.4%
EPS growth (YoY)	+32.9%
FCF/share growth (YoY)	+149.8%
Beta	0.5
Exchange	NYSE
Sector	Healthcare
Industry	Medical Distribution

CAH earnings

Next report: Feb 4, 2027 (Q2 2027, EPS estimate $3.14). Beat the EPS estimate in 4 of 4 recent quarters.

Quarter	Reported	EPS	Estimate	Surprise	Revenue
Q1 2027	Nov 5, 2026	$3.26	$2.94	+10.9%	$67.51B
Q4 2026	Aug 11, 2026	$2.60	$2.42	+7.4%	$63.67B
Q3 2026	Apr 30, 2026	$3.17	$2.79	+13.6%	$60.94B
Q2 2026	Feb 5, 2026	$2.63	$2.37	+11.0%	$65.63B

CAH analyst price target

Median target $277.00 from 15 analysts, ranging $235.00 – $295.00.

Medical Distribution peers

Ticker	Company	Market cap	P/E
MCK	McKesson	$122.48B	24.9
COR	Cencora	$63.65B	18.6
HSIC	Henry Schein	$9.51B	16.2
AHG	Akso Health Group	$1.16B	—

Explore live CAH data on Nama Insights →

Recent Congressional trades

Cardinal Health trades disclosed by members of the US House and Senate under the STOCK Act. See the full Congress trades board →

Member	Chamber	Trade	Amount	Disclosed
Alan Armstrong	Senate	Buy	$1,001 - $15,000	Jul 21, 2026
Marjorie Taylor Greene	House	Buy	$1,001 - $15,000	Oct 28, 2025
Marjorie Taylor Greene	House	Buy	$1,001 - $15,000	May 19, 2025
Rob Bresnahan	House	Buy	$1,001 - $15,000	May 8, 2025
Marjorie Taylor Greene	House	Buy	$1,001 - $15,000	May 6, 2025
Marjorie Taylor Greene	House	Buy	$1,001 - $15,000	Mar 19, 2025
Marjorie Taylor Greene	House	Buy	$1,001 - $15,000	Jan 27, 2025
Marjorie Taylor Greene	House	Buy	$1,001 - $15,000	Sep 23, 2024
John James	House	Sell	$1,001 - $15,000	Sep 6, 2024
John James	House	Buy	$1,001 - $15,000	Sep 2, 2024
John James	House	Buy	$1,001 - $15,000	Sep 2, 2024
Jonathan Jackson	House	Buy	$50,001 - $100,000	Feb 15, 2024

CAH FAQ

Is CAH a buy?: Nama's AI scorecard currently rates Cardinal Health Buy (6.5 out of 10), a call computed from its profitability, cash generation, growth, valuation and balance sheet. It is a research reading, not investment advice.
What is CAH's P/E ratio?: Cardinal Health trades at a trailing price-to-earnings ratio of 23.3.
When does CAH report earnings?: Cardinal Health's next scheduled report is on Feb 4, 2027. Analysts expect EPS of $3.14.
What is the CAH price target?: The median analyst price target from 15 analysts is $277.00, with a range of $235.00 – $295.00.
Is CAH Shariah compliant?: Nama's AAOIFI-style screen reads Cardinal Health as Shariah Compliant. Passes our debt, cash and income screen; not a scholar's ruling.
Does CAH pay a dividend?: Yes — Cardinal Health's dividend yield is 0.8%.